| MARITIMA DEL CALLAO | 2025 | 225 | KG | Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy], S/M, S/M Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy] MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | SPAIN | 5973 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.064 | KG | ATENOLOL COMPUESTO RELACIONADO B, UPS, S/M ATENOLOL RELATED COMPOUND B (25 MG) (2-[4-(2,3-DIHYDROXYPROPOXY)PHENYI]ACETAMIDE) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL X 25 MG, 1044265,LOTE:F12720 | UNITED STATES | UNITED STATES | 710.87 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.064 | KG | ATENOLOL COMPUESTO RELACIONADO A, UPS, S/M ATENOLOL RELATED COMPOUND A (50 MG) (2-(4-HYDROXYPHENYL)ACETAMIDE) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL X 50 MG, 1044254,LOTE:F12710 | UNITED STATES | UNITED STATES | 710.87 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.079 | KG | ATENOLOL COMP RELACIONADO F (USP), UPS, S/M Atenolol Related Compound F (25 mg) (2,2-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-d PRESENTACION: 25 MG, CODIGO: 1044367, LOTE: F12760 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO ATENOLOL COMP | UNITED STATES | UNITED STATES | 745.14 |
| MARITIMA DEL CALLAO | 2025 | 2500 | KG | 1,3-BENZENEDICARBOXAMIDE, 5-(ACETY(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROPY 1,3-BENZENEDICARBOXAMIDE, 5-(ACETY(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROPY MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KGS | CHINA | CHINA | 253254 |
| MARITIMA DEL CALLAO | 2025 | 3000 | KG | IOPAMIDOL COMPUESTO RELACIONADO B, S/M, S/M ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO LOTES: A02-241102,SA02-241104,SA02-241202,SA02-241103,SA02-241201,SA02-241203 IOPAMIDOL COMPUESTO RELACIONADO B IOPAMIDOL | CHINA | CHINA | 342009 |
| MARITIMA DEL CALLAO | 2025 | 1800 | KG | 1,3-BENZENEDICARBOXAMIDE,5-(ACETYL(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROPY 1,3-BENZENEDICARBOXAMIDE,5-(ACETYL(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROPY MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 182385 |
| MARITIMA DEL CALLAO | 2025 | 1600 | KG | 1,3-BENZENEDICARBOXAMIDE, 5-(ACETYL(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROP 1,3-BENZENEDICARBOXAMIDE, 5-(ACETYL(2,3-DIHYDROXYPROPYL)AMINO)-N1,N3-BIS(2,3-DIHYDROXYPROP MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | CHINA | 162083 |
| AEREA Y POSTAL EX-IAAC | 2025 | 1000 | KG | 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N 1,N3-bis(2,3-dihydroxypro 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N 1,N3-bis(2,3-dihydroxypro MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMECIALIZADO EN KILO | CHINA | CHINA | 99352 |
| AEREA Y POSTAL EX-IAAC | 2025 | 60 | KG | 2-METHYL N-( 4 - NITRO-3-(TRIFLUOROMETHYL), S/M, S/M 2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl] propenamide) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 6549.7 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.149 | KG | IOPAMIDOL COMPUESTO RELACIONADO B (USP), UPS, S/M IOPAMIDOL RELATED COMPOUND B (50 MG) (5-GIYCOIAMIDO-N,N`-BIS[2-HYDROXY-1-(HYDROXYMETHYI)E ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 2 VIALES X 50 MG, 1344735,LOTE:R07560 | UNITED STATES | UNITED STATES | 1676.78 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.02 | KG | IOPAMIDOL COMP. RELACIONADO C (USP), USP, S/M IOPAMIDOL RELATED COMPOUND C (40 MG) (4-CHLORO-N1,N3-BIS(1,3-DIHYDROXYPROPAN-2-YL)-5-(S)-L ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1344746 | UNITED STATES | UNITED STATES | 839.12 |